The role of endoglin and its soluble form in pathogenesis of preeclampsia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of endoglin and its soluble form in pathogenesis of preeclampsia
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 477, Issue 2, Pages 479-491
Publisher
Springer Science and Business Media LLC
Online
2021-11-16
DOI
10.1007/s11010-021-04294-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis
- (2021) Georgia Margioula-Siarkou et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Endoglin: Beyond the Endothelium
- (2020) Mark J.A. Schoonderwoerd et al. Biomolecules
- Endoglin Targeting: Lessons Learned and Questions That Remain
- (2020) Yingmiao Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities
- (2020) Lucía Pérez-Roque et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro
- (2019) Matej Vicen et al. FASEB JOURNAL
- Preeclampsia
- (2019) Sarosh Rana et al. CIRCULATION RESEARCH
- The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention
- (2019) Liona C. Poon et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Role of soluble endoglin in BMP9 signaling
- (2019) Aleksandra Lawera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective
- (2018) Athena Kritharis et al. HAEMATOLOGICA
- Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective
- (2018) Athena Kritharis et al. HAEMATOLOGICA
- LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia
- (2018) Hua Li et al. REPRODUCTION
- Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
- (2018) Aldona Kasprzak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction
- (2018) J. Mayrink et al. TheScientificWorldJOURNAL
- Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies
- (2017) Claudia Ollauri-Ibáñez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- TGF-β Signaling in Control of Cardiovascular Function
- (2017) Marie-José Goumans et al. Cold Spring Harbor Perspectives in Biology
- Pre-eclampsia: its pathogenesis and pathophysiolgy
- (2016) P Gathiram et al. Cardiovascular Journal of Africa
- Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines
- (2016) E. Phipps et al. Clinical Journal of the American Society of Nephrology
- Angiogenic Factors in Preeclampsia
- (2016) S. Ananth Karumanchi HYPERTENSION
- An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia
- (2016) Numan Cim et al. Journal of Maternal-Fetal & Neonatal Medicine
- Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia
- (2016) Xiru Liu et al. Journal of Maternal-Fetal & Neonatal Medicine
- Pre-eclampsia
- (2016) Ben W J Mol et al. LANCET
- Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
- (2016) Carmen Rădulescu et al. MEDIATORS OF INFLAMMATION
- LIF and LIF-R expression in the endometrium of fertile and infertile women: A prospective observational case-control study
- (2016) CHRYSOULA MARGIOULA SIARKOU et al. Molecular Medicine Reports
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
- (2015) Sandra A. Lowe et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- Increased endothelial cell permeability in endoglin-deficient cells
- (2015) Mirjana Jerkic et al. FASEB JOURNAL
- Correlations among antiangiogenic factors and trace elements in hypertensive disorders of pregnancy
- (2015) Vania B. Rezende et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin
- (2015) Leslie Pomeraniec et al. MOLECULAR BIOLOGY OF THE CELL
- Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia
- (2014) Clarissa M. Tobinaga et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis
- (2014) Rebecca E. Allen et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Advances in the pathophysiology of pre-eclampsia and related podocyte injury
- (2014) Iasmina M. Craici et al. KIDNEY INTERNATIONAL
- Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells
- (2014) F.C. Brownfoot et al. PLACENTA
- Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia
- (2014) Luiza O. Perucci et al. PLoS One
- Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension
- (2014) Benoît Gore et al. PLoS One
- Contrasting Roles of Different Endoglin Forms in Atherosclerosis
- (2014) Young-Saeng Jang et al. Immune Network
- Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
- (2013) A. C. Palei et al. Acta Physiologica
- Proteinuria in Preeclampsia from a Podocyte Injury Perspective
- (2013) Daniel E. Henao et al. CURRENT HYPERTENSION REPORTS
- Membrane and Soluble Forms of Endoglin in Preeclampsia
- (2013) B. Oujo et al. CURRENT MOLECULAR MEDICINE
- Global and regional estimates of preeclampsia and eclampsia: a systematic review
- (2013) Edgardo Abalos et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state
- (2013) Roberto Romero et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell–matrix adhesion of podocytes in physiology and disease
- (2013) Norman Sachs et al. Nature Reviews Nephrology
- Review: The enigmatic role of endoglin in the placenta
- (2013) A.L. Gregory et al. PLACENTA
- The role of endoglin in atherosclerosis
- (2012) Petr Nachtigal et al. ATHEROSCLEROSIS
- Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis
- (2012) CE Kleinrouweler et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration
- (2012) E. Rossi et al. BLOOD
- Oxysterol-Induced Soluble Endoglin Release and Its Involvement in Hypertension
- (2012) Ana C. Valbuena-Diez et al. CIRCULATION
- CD105 Protein Depletion Enhances Human Adipose-derived Stromal Cell Osteogenesis through Reduction of Transforming Growth Factor β1 (TGF-β1) Signaling
- (2011) Benjamin Levi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of TGF-β-Induced Differentiation in Human Vascular Smooth Muscle Cells
- (2011) Yuefeng Tang et al. JOURNAL OF VASCULAR RESEARCH
- Transforming Growth Factor-? and Endoglin Signaling Orchestrate Wound Healing
- (2011) Manoj Valluru et al. Frontiers in Physiology
- Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
- (2010) L. J. A. C. Hawinkels et al. CANCER RESEARCH
- Autoantibody-Mediated Angiotensin Receptor Activation Contributes to Preeclampsia Through Tumor Necrosis Factor-α Signaling
- (2010) Roxanna A. Irani et al. HYPERTENSION
- Guidelines for the management of hypertensive disorders of pregnancy 2008
- (2009) Sandra A. LOWE et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration
- (2009) Bridgette N. Ray et al. CARCINOGENESIS
- Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration
- (2009) Diana Romero et al. CARCINOGENESIS
- Endoglin in angiogenesis and vascular diseases
- (2008) Peter ten Dijke et al. ANGIOGENESIS
- Endoglin (CD105) Expression Is Regulated by the Liver X Receptor Alpha (NR1H3) in Human Trophoblast Cell Line JAR1
- (2008) Joëlle Henry-Berger et al. BIOLOGY OF REPRODUCTION
- Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression
- (2008) Jeffrey S. Gilbert et al. HYPERTENSION
- Alteration of Serum Soluble Endoglin Levels after the Onset of Preeclampsia Is More Pronounced in Women with Early-Onset
- (2008) Chikako HIRASHIMA et al. HYPERTENSION RESEARCH
- Endoglin (CD105) as a urinary and serum marker of prostate cancer
- (2008) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
- L- and S-endoglin differentially modulate TGF 1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts
- (2008) S. Velasco et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation